newsfilter
← Latest News
PR Newswire·

Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306

Alebund Pharmaceuticals ("Alebund" or the "Company"), a leading renal-focused biopharmaceutical company, today announced that it has entered into...